Category: disease
Johnson & Johnson’s COVID-19 vaccine is 85% effective against severe cases, and 66% effective overall per trial data
Another COVID-19 vaccine is almost ready to begin being distributed – a single-shot inoculation made by Johnson & Johnson’s Janssen pharmaceutical subsidiary. The company just released an efficacy report based on data from its Phase 3 trial, which found that the new vaccine is 66% effective overall in preventing moderate…
Read More
Cloudflare introduces free digital waiting rooms for any organizations distributing COVID-19 vaccines
Web infrastructure company Cloudflare is releasing a new tool today that aims to provide a way for health agencies and organizations globally tasked with rolling out COVID-19 vaccines to maintain a fair, equitable and transparent digital queue – completely free of charge. The company’s ‘Project Fair Shot’ initiative will make…
Read More
Researchers use biometrics, including data from the Oura Ring, to predict COVID-19 symptoms in advance
A team of researchers from the West Virginia University (WVU) Rockefeller Neuroscience Institute (RNI), along with WVU’s Medicine department and staff from Oura Health have developed a platform they say can be used to anticipate the onset of COVID-19 symptoms in otherwise healthy people up to three days in advance.…
Read More
LetsGetChecked raises $71 million as COVID-19 epidemic makes home-testing increasingly vital
As the country wrestles with the COVID-19 epidemic, home health testing, checkups and diagnostics have never been more important and companies like LetsGetChecked are filling a void left in a U.S. healthcare system consumed by the outbreak. The surge in demand for the company’s services has led to an equal…
Read More
Can API vendors solve healthcare’s data woes?
A functioning healthcare system depends on caregivers having the right data at the right time to make the right decision about what course of treatment a patient needs. In the aftermath of the COVID-19 epidemic and the acceleration of the consumer adoption of telemedicine, along with the fragmentation of care…
Read More
NEA-backed Personal Genome Diagnostics receives FDA clearance for its cancer diagnostic
Personal Genome Diagnostics, the venture-backed developer of a novel diagnostic kit for genomic profiling of different cancers in lab settings, has received clearance from the U.S. Food and Drug Administration for its PGDx elio tissue complete test. The test’s approval is another step forward for precision therapies that rely on…
Read More